Alosaimi M, Alkanhal H, Aldeligan S, Alkhawajah N, Albishi A, Hilabi B
Front Neurol. 2025; 15():1491193.
PMID: 39830197
PMC: 11739352.
DOI: 10.3389/fneur.2024.1491193.
Boaventura M, Fragoso D, Avolio I, Pereira S, Callegaro D, Sato D
J Neurol. 2025; 272(2):157.
PMID: 39821642
DOI: 10.1007/s00415-024-12869-1.
Chien C, Cruz E Silva V, Geiter E, Meier D, Zimmermann H, Bichuetti D
Radiology. 2024; 313(2):e233099.
PMID: 39530897
PMC: 11605104.
DOI: 10.1148/radiol.233099.
Tsai C, Combes A, McMullen K, Kolind S, Traboulsee A
J Neuroimaging. 2024; 35(1):e13250.
PMID: 39511966
PMC: 11625695.
DOI: 10.1111/jon.13250.
Zakani M, Nigritinou M, Ponleitner M, Takai Y, Hofmann D, Hillebrand S
Neuropathol Appl Neurobiol. 2023; 49(2):e12893.
PMID: 36811295
PMC: 10947283.
DOI: 10.1111/nan.12893.
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Muto M
J Neurol Neurosurg Psychiatry. 2021; 93(1):32-40.
PMID: 34362853
PMC: 8685614.
DOI: 10.1136/jnnp-2021-326386.
A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon J, Paul F, Chien C, Oh J, Rotstein D
Ther Adv Neurol Disord. 2021; 14:17562864211014389.
PMID: 34035837
PMC: 8111516.
DOI: 10.1177/17562864211014389.
Transdiagnostic hippocampal damage patterns in neuroimmunological disorders.
Heine J, Pruss H, Scheel M, Brandt A, Gold S, Bartsch T
Neuroimage Clin. 2021; 28:102515.
PMID: 33396002
PMC: 7721635.
DOI: 10.1016/j.nicl.2020.102515.
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study.
Schmidt F, Chien C, Kuchling J, Bellmann-Strobl J, Ruprecht K, Siebert N
Front Neurol. 2020; 11:499910.
PMID: 33101166
PMC: 7554609.
DOI: 10.3389/fneur.2020.499910.
Cognitive impairment in NMOSD-More questions than answers.
Czarnecka D, Oset M, Karlinska I, Stasiolek M
Brain Behav. 2020; 10(11):e01842.
PMID: 33022898
PMC: 7667314.
DOI: 10.1002/brb3.1842.
Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study.
Chien C, Oertel F, Siebert N, Zimmermann H, Asseyer S, Kuchling J
Brain Commun. 2020; 1(1):fcz026.
PMID: 32954267
PMC: 7425339.
DOI: 10.1093/braincomms/fcz026.
Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Kuchling J, Paul F
Front Neurol. 2020; 11:450.
PMID: 32625158
PMC: 7311777.
DOI: 10.3389/fneur.2020.00450.
Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.
Chawla S, Ge Y, Wuerfel J, Asadollahi S, Mohan S, Paul F
Mult Scler Relat Disord. 2020; 42:102066.
PMID: 32272444
PMC: 7410392.
DOI: 10.1016/j.msard.2020.102066.
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features.
Oertel F, Schliesseit J, Brandt A, Paul F
Front Neurol. 2019; 10:608.
PMID: 31258505
PMC: 6587817.
DOI: 10.3389/fneur.2019.00608.
Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier B, Borisow N, Rasche L, Bellmann-Strobl J, Ruprecht K, Niendorf T
Neurol Neuroimmunol Neuroinflamm. 2019; 6(3):e541.
PMID: 30882018
PMC: 6410932.
DOI: 10.1212/NXI.0000000000000541.
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.
Borisow N, Mori M, Kuwabara S, Scheel M, Paul F
Front Neurol. 2018; 9:888.
PMID: 30405519
PMC: 6206299.
DOI: 10.3389/fneur.2018.00888.
Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.
Borisow N, Hellwig K, Paul F
EPMA J. 2018; 9(3):249-256.
PMID: 30174761
PMC: 6107451.
DOI: 10.1007/s13167-018-0143-9.
Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability.
Zhang X, Guo X, Zhang N, Cai H, Sun J, Wang Q
Front Neurol. 2018; 9:305.
PMID: 29780351
PMC: 5946009.
DOI: 10.3389/fneur.2018.00305.
MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.
Chien C, Brandt A, Schmidt F, Bellmann-Strobl J, Ruprecht K, Paul F
AJNR Am J Neuroradiol. 2018; 39(7):1362-1368.
PMID: 29748202
PMC: 7655445.
DOI: 10.3174/ajnr.A5665.
The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M
Nat Rev Neurol. 2018; 14(4):199-213.
PMID: 29521337
DOI: 10.1038/nrneurol.2018.14.